Chiang, A. S., Loblaw, D. A., Jethava, V., Sethukavalan, P., Zhang, L., Vesprini, D., . . . Klotz, L. (2013). Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer. Canadian Medical Association.

Chiang, Andrew S., D. Andrew Loblaw, Vibhuti Jethava, Perakaa Sethukavalan, Liying Zhang, Danny Vesprini, Alexandre Mamedov, Robert Nam, e Laurence Klotz. Utility of 5-alpha-reductase Inhibitors in Active Surveillance for Favourable Risk Prostate Cancer. Canadian Medical Association, 2013.

Chiang, Andrew S., et al. Utility of 5-alpha-reductase Inhibitors in Active Surveillance for Favourable Risk Prostate Cancer. Canadian Medical Association, 2013.